Alcami Corporation, a contract development and manufacturing organization (CDMO), has entered a new strategic partnership with Tanvex CDMO, a biologics developer offering pre-clinical to commercial biologic CDMO services, through which Alcami and Tanvex will offer clients a complete solution from bulk drug substance production through to finished drug product—pairing Alcami’s expertise in liquid and lyophilization sterile filling, packaging, and labeling with Tanvex’s high-throughput bulk drug s...